DRUG PROFILING & MOA

Accurate in vitro pharmacological profiling at an early stage is critical for lead optimization. Combining live content and high-content imaging, Fluofarma developed a cost-efficient strategy to accurately determine the efficacy and toxicity profile of lead coumpounds, and explore their underlying mechanism of action.

In addition to in vitro mechanistic studies, Fluofarma offers to validate the mechanism of action of lead compounds in vivo, through the multiplexed quantification of biomarkers in blood or tissue samples by high-content analysis.